Pratt C W, Macik B G, Church F C
Department of Medicine, University of North Carolina School of Medicine, Chapel Hill 27599.
Thromb Res. 1989 Mar 15;53(6):595-602. doi: 10.1016/0049-3848(89)90149-7.
Protein C inhibitor was purified from human plasma by a modification of a published procedure (Suzuki, K., Nishioka, J., and Hashimoto, S. J. Biol. Chem. 258, 163-168, 1983). Approximately 1 mg of pure protein was obtained from 1 L plasma, a yield of about 17%. The protein C inhibitor preparation did not lose activity over 4 weeks at 4 degrees C. Second order rate constants were measured for the inhibition of activated protein C, thrombin, and urokinase, and bimolecular complexes of protein C inhibitor with activated protein C and thrombin were visualized by denaturing polyacrylamide gel electrophoresis. Heparin accelerated the inhibition of the three proteinases in a manner consistent with a template mechanism. Plasma or pure protein C inhibitor (at the same concentration) showed the same effect of heparin on activated protein C inhibition, indicating that protein C inhibitor accounts for all the heparin-dependent inhibition of activated protein C in vivo.
通过对已发表方法(铃木,K.,西冈,J.,和桥本,S.《生物化学杂志》258,163 - 168,1983)进行改进,从人血浆中纯化出蛋白C抑制剂。从1升血浆中大约获得了1毫克纯蛋白,产率约为17%。蛋白C抑制剂制剂在4℃下4周内不会丧失活性。测定了对活化蛋白C、凝血酶和尿激酶抑制作用的二级速率常数,并通过变性聚丙烯酰胺凝胶电泳观察了蛋白C抑制剂与活化蛋白C和凝血酶的双分子复合物。肝素以与模板机制一致的方式加速了对这三种蛋白酶的抑制作用。血浆或纯蛋白C抑制剂(浓度相同)对活化蛋白C抑制作用表现出相同的肝素效应,表明蛋白C抑制剂是体内所有依赖肝素对活化蛋白C抑制作用的原因。